American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Petros Pharmaceuticals, Inc. (PTPI)

$0.00 -6.67% OTC: PTPI · 15-min delayed

NEW YORK, New York
Public · OTC: PTPI

Visit website Follow

$5.1MRevenue · FY2024

$1.9MNet income

PTPIOTC

About Petros Pharmaceuticals, Inc.

PETROS PHARM INC

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: PTPI
Headquarters: NEW YORK, New York
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: PTPI OTC
SEC CIK: 1815903
EIN: 851410058
SIC: 2834 Pharmaceutical Preparations

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Petros Pharmaceuticals, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/petros-pharmaceuticals-inc/"><img src="https://americancompanies.com/badge/petros-pharmaceuticals-inc.svg" alt="Petros Pharmaceuticals, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Petros Pharmaceuticals, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2024: $5.1M
Net income: $1.9M
Total assets: $5.2M

Source: SEC EDGAR · updated Jun 8, 2026

OTC: PTPI

$0.00 -6.67%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.00 $0.03

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Petros Pharmaceuticals, Inc. (PTPI) Stock Price

Profitable — net income of $1.9M in FY2024.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

CNS Pharmaceuticals, Inc.CNSP

No reviews yet. Be the first to review Petros Pharmaceuticals, Inc..

Write a review

Newsroom

News about Petros Pharmaceuticals, Inc.

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Benzinga · 2024-04-02 Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Benzinga · 2024-01-30 Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket Benzinga · 2024-01-30 Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket Benzinga · 2023-12-13 Why Brooge Energy Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket Benzinga · 2023-10-04 Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket Benzinga · 2023-07-13

News & sentiment via Polygon.io

FAQ

Petros Pharmaceuticals, Inc.: frequently asked questions

Is Petros Pharmaceuticals, Inc. an American company?

Petros Pharmaceuticals, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Petros Pharmaceuticals, Inc. headquartered?

Petros Pharmaceuticals, Inc. is headquartered in New York, New York, United States.

Is Petros Pharmaceuticals, Inc. publicly traded?

Yes — Petros Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol PTPI on the OTC.

What does Petros Pharmaceuticals, Inc. do?

Petros Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore